ABOUT US PIPELINE INVESTORS CAREERS COMPANY OVERVIEW Bavarian Nordic focuses on developing product candidates to address cancer and infectious diseases by leveraging several core strengths: Existing revenue generation advances our growth Our existing revenue generation from our research and development, supply contracts, and commercial partnerships can be used to invest in the advancement of our clinical pipeline. Modular and proprietary vaccine technology Our vaccine platform takes a modular approach to live virus vaccine development and is based on the use of different types of poxviruses, notably our MVA-BN viral vector with a favorable safety profile. These viruses can be used in various combinations for both the prime and booster applications in both cancer and infectious diseases. Commercial-scale cGMP production facility Our ability to effectively and efficiently produce our live virus vaccines has been demonstrated by our production of more than 28 million doses of IMVAMUNE smallpox vaccine and more than 2 million doses of our MVA-BN Filo product candidate for Ebola to date, as well as production of all clinical materials. Ongoing relationships with government agencies We have entered into research and development contracts with the U.S. Government worth more than USD 1.2 billion in revenue. Contract partners include HHS, NIH, BARDA, NCI, DOD, and the DHS, spanning multiple disease areas and biological threats. Collaborations with Bristol-Myers Squibb and Janssen We have a global commercialization agreement for PROSTVAC with Bristol-Myers Squibb. In addition, we have a partnership with Janssen, under which we have outlicensed our MVA-BN vaccine technology for Ebola and HPV vaccines. COMPANY OVERVIEW Cancer Immunotherapy Infectious Diseases Manufacturing FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.